scholarly article | Q13442814 |
P356 | DOI | 10.1097/TP.0B013E3182187CF0 |
P698 | PubMed publication ID | 21617590 |
P50 | author | Alessandro Cucchetti | Q38323998 |
Giorgio Ercolani | Q38324012 | ||
Gian Luca Grazi | Q56424514 | ||
Matteo Ravaioli | Q87935878 | ||
Matteo Cescon | Q90455067 | ||
Massimo Del Gaudio | Q90455071 | ||
Golfieri Rita | Q98581110 | ||
Antonio Daniele Pinna | Q114325333 | ||
Valentina Rosa Bertuzzo | Q117260468 | ||
Antonietta D'Errico-Grigioni | Q117260469 | ||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | inflammation | Q101991 |
hepatocellular carcinoma | Q1148337 | ||
liver transplantation | Q1368191 | ||
P304 | page(s) | 1279-1285 | |
P577 | publication date | 2011-06-01 | |
P1433 | published in | Transplantation | Q15730500 |
P1476 | title | Analysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers | |
P478 | volume | 91 |
Q38059620 | A systematic review of microvascular invasion in hepatocellular carcinoma: diagnostic and prognostic variability. |
Q38269467 | Biological markers of hepatocellular carcinoma for use as selection criteria in liver transplantation |
Q39112472 | Blood neutrophil to lymphocyte ratio as a predictor in patients with advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy |
Q47147429 | Combination of the neutrophil to lymphocyte ratio and the platelet to lymphocyte ratio as a useful predictor for recurrence following radiofrequency ablation of hepatocellular carcinoma |
Q48009815 | Combination with CK19 Might Increase the Prognostic Power of Hep Par 1 in Hepatocellular Carcinoma after Curative Resection |
Q41054345 | Combined Hangzhou criteria with neutrophil-lymphocyte ratio is superior to other criteria in selecting liver transplantation candidates with HBV-related hepatocellular carcinoma. |
Q47614432 | Critical evaluation of the American Joint Commission on Cancer (AJCC) 8th edition staging system for patients with Hepatocellular Carcinoma (HCC): A Surveillance, Epidemiology, End Results (SEER) analysis |
Q89476590 | DNA methylation of SOCS1/2/3 predicts hepatocellular carcinoma recurrence after liver transplantation |
Q44653651 | Donor factors similarly impact survival outcome after liver transplantation in hepatocellular carcinoma and non-hepatocellular carcinoma patients |
Q50244060 | Downstaging advanced hepatocellular carcinoma to the Milan criteria may provide a comparable outcome to conventional Milan criteria |
Q36406952 | Effects of antiviral therapy on the recurrence of hepatocellular carcinoma after curative resection or liver transplantation. |
Q26769591 | Elevated Preoperative Neutrophil-Lymphocyte Ratio Is Associated with Poor Prognosis in Hepatocellular Carcinoma Patients Treated with Liver Transplantation: A Meta-Analysis |
Q41439820 | Expression and Significances of G-Protein-Coupled Receptor Kinase 3 in Hepatocellular Carcinoma |
Q44606962 | Hepatic venous congestion in living donor grafts in liver transplantation: is there an effect on hepatocellular carcinoma recurrence? |
Q44696972 | Impact of tumor size, number of tumors and neutrophil-to-lymphocyte ratio in liver transplantation for recurrent hepatocellular carcinoma |
Q44165064 | Inflammatory markers are associated with outcome in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization |
Q28074653 | Liver transplantation for advanced hepatocellular carcinoma |
Q38821374 | Liver transplantation for hepatobiliary malignancies: a new era of "Transplant Oncology" has begun |
Q38177251 | Liver transplantation for hepatocellular carcinoma: role of inflammatory and immunological state on recurrence and prognosis |
Q84496768 | Liver transplantation: a simple inflammation marker predicts liver cancer prognosis |
Q38221424 | Mammalian target of rapamycin inhibitors are associated with lower rates of hepatocellular carcinoma recurrence after liver transplantation: a systematic review. |
Q42333014 | Milan criteria and its expansions in liver transplantation for hepatocellular carcinoma |
Q53548609 | Neutrophil-lymphocyte and platelet-lymphocyte ratio in patients after resection for hepato-pancreatico-biliary malignancies. |
Q36756063 | Neutrophil-lymphocyte ratio predicts overall and recurrence-free survival after liver transplantation for hepatocellular carcinoma |
Q37378982 | Neutrophil-lymphocyte ratio predicts the prognosis of patients with hepatocellular carcinoma after liver transplantation |
Q87509976 | Neutrophil-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinoma |
Q39333416 | Neutrophil-to-lymphocyte ratio as a predictor of outcomes for patients with hepatocellular carcinoma: a Western perspective |
Q45358708 | Neutrophil-to-lymphocyte ratio associated with mortality in early hepatocellular carcinoma patients after radiofrequency ablation |
Q36052780 | Neutrophil-to-lymphocyte ratio for the prognostic assessment of hepatocellular carcinoma: A systematic review and meta-analysis of observational studies |
Q41734066 | Neutrophil-to-lymphocyte ratio predicts mortality in patients listed for liver transplantation |
Q41544562 | Novel Pretreatment Scoring Incorporating C-reactive Protein to Predict Overall Survival in Advanced Hepatocellular Carcinoma with Sorafenib Treatment |
Q40235716 | Postoperative peak serum C-reactive protein is a predictor of outcome following liver transplantation for hepatocellular carcinoma |
Q37725550 | Pre-radiotherapy neutrophil-to-lymphocyte ratio as an independent prognostic factor in patients with locally advanced hepatocellular carcinoma treated with radiotherapy |
Q26772329 | Prediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantation |
Q64085445 | Preoperative Neutrophil-to-Lymphocyte Ratio Plus Platelet-to-Lymphocyte Ratio Predicts the Outcomes after Curative Resection for Hepatocellular Carcinoma |
Q33912315 | Preoperative Neutrophil-to-Lymphocyte Ratio as a New Prognostic Marker in Hepatocellular Carcinoma after Curative Resection. |
Q50195636 | Pretreatment neutrophil-lymphocyte ratio: useful prognostic biomarker in hepatocellular carcinoma |
Q40212610 | Prognostic prediction of male recipients selected for liver transplantation: With special attention to neutrophil to lymphocyte ratio |
Q36746912 | Prognostic role of C-reactive protein in hepatocellular carcinoma: a systematic review and meta-analysis |
Q33589014 | Prognostic significance of neutrophil-lymphocyte ratio in hepatocellular carcinoma: a meta-analysis |
Q35161694 | Prognostic significance of the neutrophil-to-lymphocyte ratio in primary liver cancer: a meta-analysis |
Q31111026 | Prognostic value of C-reactive protein and neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma |
Q35534078 | Prognostic value of neutrophil distribution in cholangiocarcinoma |
Q33652003 | Prognostic value of the neutrophil-to-lymphocyte ratio for hepatocellular carcinoma patients with portal/hepatic vein tumor thrombosis |
Q42237455 | Radiological response and inflammation scores predict tumour recurrence in patients treated with transarterial chemoembolization before liver transplantation. |
Q52620441 | Reactivation of hepatitis B after liver transplantation: Current knowledge, molecular mechanisms and implications in management. |
Q38594469 | Recurrence of hepatocellular carcinoma after liver transplantation: an update |
Q35799223 | Relationship of preoperative neutrophil lymphocyte ratio with prognosis in gastrointestinal stromal tumors |
Q34038193 | Retracted: A Scoring Model Based on Neutrophil to Lymphocyte Ratio Predicts Recurrence of HBV-Associated Hepatocellular Carcinoma after Liver Transplantation |
Q47649573 | Risk factors of early recurrence after curative hepatectomy in hepatocellular carcinoma |
Q89701689 | Role of inflammatory markers as hepatocellular cancer selection tool in the setting of liver transplantation |
Q38818641 | Serologic and molecular biomarkers for recurrence of hepatocellular carcinoma after liver transplantation: A systematic review and meta-analysis. |
Q61443474 | Serum biomarkers and risk of hepatocellular carcinoma recurrence after liver transplantation |
Q55289894 | Significance of serum ferritin as a prognostic factor in advanced hepatobiliary cancer patients treated with Korean medicine: a retrospective cohort study. |
Q27005375 | Strategies to improve outcome of patients with hepatocellular carcinoma receiving a liver transplantation |
Q50158378 | The Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio Are Prognostic Factors in Patients with Locally Advanced Pancreatic Cancer Treated with Chemoradiotherapy |
Q37436505 | The predictive value of blood neutrophil-lymphocyte ratio in patients with end-stage liver cirrhosis following ABO-incompatible liver transplantation |
Q47338550 | The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: Systematic review and meta-analysis. |
Q37001415 | The systemic inflammatory response as a prognostic factor for advanced hepatocellular carcinoma with extrahepatic metastasis |
Q64085297 | Treatment selection of recurrent hepatocellular carcinoma with microvascular invasion at the initial hepatectomy |
Q45405877 | Two-step selection criteria for living donor liver transplantation in patients with hepatocellular carcinoma |
Q60932844 | Utility and Limitation of Preoperative Neutrophil Lymphocyte Ratio as a Prognostic Factor in Hepatocellular Carcinoma |
Search more.